ClinicalThought

Share

Program Content

Activities

  • Renal Protection in T2D
    Why I Recommend SGLT2 Inhibitors for Renal Protection in Patients With T2D
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 21, 2021

    Expires: June 20, 2022

Provided by

ProCE Banner

Supporters

Merck